துணிகர கூட்டாளர்கள் சீனா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from துணிகர கூட்டாளர்கள் சீனா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In துணிகர கூட்டாளர்கள் சீனா Today - Breaking & Trending Today

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial
News provided by
Share this article
Share this article
1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the phase III China clinical trial (PaTHway China Trial) of TransCon PTH Solution for Injection (TransCon™ parathyroid hormone).
2. PaTHway China Trial is designed to assess the potential of TransCon™ PTH as a hormone replacement therapy, and the aim is to enable patients to have serum calcium (sCa) within the normal range and independence from usual care. ....

United States , Hong Kong , Jun Yang , Ascendis Pharma , Bone Mineral Research , Item Short Form Health Survey , National Medical Products Administration , Chinese Society Of Osteoporosis , Drug Evaluation , China Trial , Subcutaneous Infection , World Hypopara Awareness , Hypoparathyroidism Patient Experience Scale , Short Form Health Survey , World Hypopara Awareness Day , Greater China , Pharma Announces Orphan Drug Designation Granted , Hypoparathyroidism Retrieved Jun , Vivo Capital , Sofinnova Investments , Sequoia China , Sherpa Healthcare Partners , Venture Partners China , Logos Capital , Visen Pharma , ஒன்றுபட்டது மாநிலங்களில் ,

VISEN's TransCon Human Growth Hormone Phase-III Clinical Trial in China Completes Target Patient Recruitment Number as Scheduled

VISEN's TransCon Human Growth Hormone Phase-III Clinical Trial in China Completes Target Patient Recruitment Number as Scheduled
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Ascendis Pharma , Luo Xiaoping , Huazhong University Of Science , Chinese Medical Association , Htm Technology , Department Of Pediatrics , Chinese Pediatric Society , Professor Luo Xiaoping , Tongji Hospital , Huazhong University , Chinese Medical , Transient Conjugation , License Application , Investigational New Drug Application , Biologics License Application , Marketing Authorization Application , European Union , Vivo Capital , Sofinnova Investments , Sequoia China , Sherpa Healthcare Partners , Venture Partners China , Logos Capital , Greater China ,

Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization

Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization
News provided by
Share this article
Share this article
SHANGHAI, March 9, 2021 /PRNewswire/ Arctic Vision, a China-based clinical-stage ophthalmology company focused on developing innovative therapies for pan-ocular diseases, today announced the completion of over US$100 million Series B financing. The Series B round was led by Loyal Valley Capital, with participation from Tencent, Octagon Capital, and Dr. Adrian Cheng, renowned entrepreneur from New World Development Group, along with existing investors Nan Fung Life Sciences, Pivotal bioVenture Partners China and Morningside Ventures. The proceeds will continue to support the progress of Arctic Vision s pipeline, including clinical developments, registrational activities, and commercialization; as well as the establishment of in-house R&D capabilities; busine ....

United States , Adrian Cheng , Roy Xie , Dianna Qian , Chow Tai Fook , Innocare Pharma , Junshi Biosciences , Teddy Wu , Nan Fung Group , Nan Fung Life Sciences , World Development , Chief Executive Officer , Board Director , Arctic Vision , Loyal Valley Capital , Venture Partners China , Venture Partners , Valley Capital , Didi Chuxing , Octagon Capital Advisors , Octagon Capital , New World Development , Alphamab Oncology , Sanbo Brain , Fung Life Sciences , Nan Fung ,

Chinese ophthalmology firm Arctic Vision snags over $100m in Series B round

Chinese ophthalmology firm Arctic Vision snags over $100m in Series B round
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Roy Xie , Adrian Cheng , Chow Tai Fook , Hong Kong Chan , Teddy Wu , Nan Fung Life Sciences , World Development Group , Arctic Vision , Loyal Valley , Octagon Capital , New World Development Group , Chow Tai , Venture Partners China , Morningside Ventures , Loyal Valley Capital , Investigational New Drug , Board Director , ஹாங் காங் , ராய் க்ஷிஎ , சோவ் தை பூக் , ஹாங் காங் சான் , எடி வு , நான் பூஞ்சை வாழ்க்கை அறிவியல் , உலகம் வளர்ச்சி குழு , ஆர்க்டிக் பார்வை ,

Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization

Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Adrian Cheng , Roy Xie , Dianna Qian , Chow Tai Fook , Innocare Pharma , Junshi Biosciences , Teddy Wu , Nan Fung Group , Nan Fung Life Sciences , World Development , Chief Executive Officer , Board Director , Arctic Vision , Loyal Valley Capital , Venture Partners China , Venture Partners , Valley Capital , Didi Chuxing , Octagon Capital Advisors , Octagon Capital , New World Development , Alphamab Oncology , Sanbo Brain , Fung Life Sciences , Nan Fung ,